PROF (Profound Medical Corp.) שווי פירמה כולל

Profound Medical Corp. (PROF) is optimizing costs by outsourcing hardware production and cloud services to external partners. Business revenues rely on the demand for the TULSA-PRO system and the sale of high-margin consumables. The current Enterprise Value stands at 171.85. The high cost of procedures, driven by the uniqueness of the prostate ablation method, and the price chart clearly demonstrate the issuer's market position.

The developer of the TULSA-PRO system utilizes MRI navigation for minimally invasive therapy, making Profound Medical Corp. (PROF) an attractive acquisition target. By analyzing the enterprise value including net debt, an investor can determine the actual buyout price of the company, where market capitalization is adjusted for the difference between liabilities and liquidity, allowing for a real-time assessment of how the cost of debt impacts the overall market value of the business.